Avedro, Inc. Completes $26 Million Offering
2/21/2012 8:30:07 AM
Avedro, Inc., a medical device company focused on vision correction, completed a $26 million round of financing in a mixed securities offering. Named in the related amended SEC filing were President and CEO David F. Muller, Chief Accounting Officer Rhonda J. Bracey; and directors and presumed investors Doug Cole, Cambridge, Mass.-based Flagship Ventures; Jeff Dykan, Wayne, Pa.-based SCP Vitalife Partners; Philip J. Ferneau, Hanover, N.H.-based Borealis Ventures; M. Carl Johnson, III, DelMonte Foods; Joseph Mandato, Palo Alto, Calif.-based DeNovo Ventures; and Anthony J. Natale, Venice, Calif.-based Prism VentureWorks.
comments powered by